dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Schettini, Francesco |
dc.contributor.author | Chic, Nuria |
dc.contributor.author | Brasó-Maristany, Fara |
dc.contributor.author | Pascual, Tomás |
dc.contributor.author | Conte, Benedetta |
dc.contributor.author | Peg Camara, Vicente |
dc.contributor.author | Fasani, Roberta |
dc.contributor.author | Paré, Laia |
dc.date.accessioned | 2021-06-11T12:27:23Z |
dc.date.available | 2021-06-11T12:27:23Z |
dc.date.issued | 2021-01-04 |
dc.identifier.citation | Schettini F, Chic N, Brasó-Maristany F, Paré L, Pascual T, Conte B, et al. Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer. npj Breast Cancer. 2021 Jan 4;7:1. |
dc.identifier.issn | 2374-4677 |
dc.identifier.uri | https://hdl.handle.net/11351/6055 |
dc.description | Càncer de mama; Genòmica del càncer; Recerca translacional |
dc.description.sponsorship | This work was supported by the grants from the European Union’s Horizon 2020 Research and Innovation Programme under Grant agreement No. 847912 (to A.P.), the Instituto de Salud Carlos III-PI16/00904 (to A.P.), Pas a Pas (to A.P.), Save the Mama (to A.P.), Breast Cancer Now-2018NOVPCC1294 (to A.P.), Fundación Científica Asociación Española Contra el Cáncer-Ayuda Postdoctoral AECC 2017 (to F.B.-M.), Fundación SEOM, Becas FSEOM para Formación en Investigación en Centros de Referencia en el Extranjero 2018 (to T.P.) and PhD4MD - Departament de Salut expedient SLT008/18/00122 (to N.C.). |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | npj Breast Cancer;7 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Expressió gènica |
dc.subject | Mama - Càncer |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | Gene Expression Profiling |
dc.subject.mesh | /genetics |
dc.title | Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41523-020-00208-2 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | perfiles de expresión génica |
dc.subject.decs | /genética |
dc.relation.publishversion | https://www.nature.com/articles/s41523-020-00208-2 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Schettini F] Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Chic N] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. [Brasó-Maristany F] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. [Paré L] SOLTI Breast Cancer Research Group, Barcelona, Spain. [Pascual T] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. Department of Genetics, University of North Carolina, Chapel Hill, NC, USA. [Conte B] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. Department of Medical Oncology, Ospedale Policlinico San Martino, University of Genova, Genova, Italy. [Peg V] Vall d’Hebron Hospital Universitari, Barcelona, Spain. GEICAM, Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain. [Fasani R] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 33397968 |
dc.identifier.wos | 000607106700001 |
dc.relation.projectid | info:eu-repo/grantAgreement/EC/H2020/847912 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00904 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/SLT008%2F18%2F00122 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |